Healthcare Professional Check

This website is intended for diabetes healthcare professionals. Click one of the options below to access the content.

You are here

Efficacy and Safety for Primary Care Physicians

for Primary Care Physicians

In this course you will learn about basal insulin–glucagon-like peptide-1 (GLP-1) receptor agonist combination therapy, and how the efficacy and safety of this approach surpasses that of the individual components. The course will provide information on how to identify patients who are most likely to benefit from this combination. Practical considerations will be discussed, including tips on how to best manage patients during treatment with basal insulin–GLP-1 receptor agonist combination therapy.

Course contents

  • Infographic

    Safety profile of basal insulin–GLP-1 RA combination

    • Lower risk of hypoglycaemia and less weight gain than insulin component
    • Fewer gastrointestinal side effects than GLP-1 RA component
    • Other adverse events
  • Anitmated e-learning

    Improved efficacy outcomes with basal insulin–GLP-1 RA combination in T2D patients

    Clinical efficacy on:

    • glycated haemoglobin A1c reduction, FPG and PPG control
    • weight
    • hypoglycaemia
  • Webcast

    Practical considerations in using basal insulin–GLP-1 RA combination

    • Dosage and administration
    • Use of basal insulin–GLP1 RA combination as insulin initiation treatment or as an alternative to adding bolus insulin
  • Selected article

    Treatment intensification in patients with inadequate glycemic control on basal insulin: rationale and clinical evidence for the use of short-acting and other glucagon-like peptide-1 receptor agonists

  • Selected article

    IDegLira: Redefining insulin optimisation using a single injection in patients with type 2 diabetes

  • Selected article

    Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis

Courses are now online!

Register for the Insulin Educational program and start any available content whenever you want. You can sign up to the E-alert list to be notified when new courses or course modules are uploaded.

Search this site

Search form


Developed by Elsevier B.V., supported by an unrestricted educational grant from Novo Nordisk